Inherited Cancer Syndrome

Inherited Cancer Syndrome refers to a group of genetic conditions that significantly increase an individual’s risk of developing certain types of cancer. Understanding these syndromes is crucial for early detection, prevention strategies, and personalized medical management.

Inherited Cancer Syndrome

Key Takeaways

  • Inherited Cancer Syndromes are genetic conditions that elevate cancer risk.
  • They are caused by specific gene mutations passed down through families.
  • Recognizing family cancer patterns and specific signs can prompt genetic evaluation.
  • Genetic testing helps identify individuals at higher risk, guiding prevention and screening.

What is Inherited Cancer Syndrome?

An Inherited Cancer Syndrome refers to a group of conditions characterized by an increased risk of developing certain cancers due to inherited genetic mutations. These mutations are passed down from a parent to a child, affecting genes that normally help protect the body from cancer, such as tumor suppressor genes or DNA repair genes. While all cancers involve genetic changes, only about 5-10% of all cancers are thought to be directly linked to inherited gene mutations, according to the American Cancer Society. This means that individuals with an inherited cancer syndrome have a higher likelihood of developing cancer at an earlier age, having multiple primary cancers, or having rare cancers.

Genetic Predisposition to Cancer Explained

A genetic predisposition to cancer means an individual has inherited specific genetic mutations that make them more susceptible to developing cancer. These mutations are present in every cell of the body from birth, unlike acquired mutations that happen during a person’s lifetime. The inherited cancer syndrome causes stem from these germline mutations, which can disrupt critical cellular processes. For instance, mutations in genes like BRCA1 and BRCA2, associated with hereditary breast and ovarian cancer syndrome, impair DNA repair mechanisms, allowing damaged cells to proliferate and potentially become cancerous. Other examples include mutations in the MLH1, MSH2, MSH6, and PMS2 genes, which are linked to Lynch syndrome, increasing the risk of colorectal and endometrial cancers. These inherited changes don’t guarantee cancer development but significantly elevate the lifetime risk compared to the general population.

  • Tumor Suppressor Genes: These genes normally slow down cell division, repair DNA mistakes, or tell cells when to die (apoptosis). Inherited mutations can render one copy of these genes non-functional.
  • DNA Repair Genes: These genes are responsible for fixing errors that occur during DNA replication. Mutations here lead to an accumulation of errors, increasing the chance of cancer-causing mutations.
  • Oncogenes: While less common for inherited syndromes, some inherited mutations can activate oncogenes, which promote cell growth and division.

Signs of Inherited Cancer Syndromes

Recognizing the signs of inherited cancer syndromes is crucial for timely genetic counseling and potential early intervention. These signs often manifest as specific patterns within a family’s medical history or unusual characteristics of cancer development. It’s important to note that the presence of one or more of these signs does not confirm an inherited syndrome but warrants further investigation.

Common indicators that might suggest an inherited cancer syndrome include:

  • Cancer diagnosed at an unusually young age (e.g., breast cancer before age 50, colorectal cancer before age 50).
  • Multiple close family members (on the same side of the family) having the same type of cancer or related cancers (e.g., breast and ovarian cancer, colon and uterine cancer).
  • An individual having more than one primary cancer (e.g., breast cancer in both breasts, or breast cancer and ovarian cancer).
  • Rare cancers in the family, such as male breast cancer, medullary thyroid cancer, or retinoblastoma.
  • Specific physical findings associated with certain syndromes (e.g., multiple polyps in the colon at a young age, certain skin lesions).
  • Ancestry that is associated with a higher prevalence of specific inherited mutations (e.g., Ashkenazi Jewish ancestry and BRCA mutations).

If these patterns are observed, consulting with a healthcare professional or a genetic counselor is recommended to assess the risk and discuss appropriate screening, prevention strategies, and genetic testing options.

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.